Hostnames |
a23-222-218-57.deploy.static.akamaitechnologies.com drugs.com |
Domains | akamaitechnologies.com drugs.com |
Country | Mexico |
City | Mexico City |
Organization | Akamai Technologies, Inc. |
ISP | Akamai Technologies, Inc. |
ASN | AS16625 |
-1177539689 | 2024-10-03T10:05:07.45902580 / tcp
HTTP/1.0 400 Bad Request Server: AkamaiGHost Mime-Version: 1.0 Content-Type: text/html Content-Length: 310 Expires: Thu, 03 Oct 2024 10:05:07 GMT Date: Thu, 03 Oct 2024 10:05:07 GMT Connection: close
-681494176 | 2024-10-03T14:10:52.337934443 / tcp
HTTP/1.0 400 Bad Request Server: AkamaiGHost Mime-Version: 1.0 Content-Type: text/html Content-Length: 310 Expires: Thu, 03 Oct 2024 14:10:52 GMT Date: Thu, 03 Oct 2024 14:10:52 GMT Connection: close
Certificate: Data: Version: 3 (0x2) Serial Number: 08:15:44:ae:97:07:72:93:ac:87:eb:19:37:61:16:54 Signature Algorithm: ecdsa-with-SHA384 Issuer: C=US, O=DigiCert Inc, CN=DigiCert Global G3 TLS ECC SHA384 2020 CA1 Validity Not Before: Jun 25 00:00:00 2024 GMT Not After : Jul 22 23:59:59 2025 GMT Subject: C=NZ, L=Auckland, O=Drugsite Limited, CN=*.drugs.com Subject Public Key Info: Public Key Algorithm: id-ecPublicKey Public-Key: (256 bit) pub: 04:e2:05:1b:c7:0a:95:c8:7d:f3:73:8a:59:00:fe: 52:35:d2:3f:c4:91:7c:22:c3:e1:33:bd:a5:93:20: 92:7a:2f:2a:bb:14:33:c4:00:58:37:67:cb:3c:12: 01:17:db:c3:24:5f:98:f4:1f:c1:1b:10:80:29:9a: c9:34:23:a5:e5 ASN1 OID: prime256v1 NIST CURVE: P-256 X509v3 extensions: X509v3 Authority Key Identifier: 8A:23:EB:9E:6B:D7:F9:37:5D:F9:6D:21:39:76:9A:A1:67:DE:10:A8 X509v3 Subject Key Identifier: 69:E3:07:74:6B:7C:8C:83:F9:85:CE:9C:08:C8:86:37:01:70:AC:1D X509v3 Subject Alternative Name: DNS:*.drugs.com, DNS:drugs.com X509v3 Certificate Policies: Policy: 2.23.140.1.2.2 CPS: http://www.digicert.com/CPS X509v3 Key Usage: critical Digital Signature, Key Agreement X509v3 Extended Key Usage: TLS Web Server Authentication, TLS Web Client Authentication X509v3 CRL Distribution Points: Full Name: URI:http://crl3.digicert.com/DigiCertGlobalG3TLSECCSHA3842020CA1-2.crl Full Name: URI:http://crl4.digicert.com/DigiCertGlobalG3TLSECCSHA3842020CA1-2.crl Authority Information Access: OCSP - URI:http://ocsp.digicert.com CA Issuers - URI:http://cacerts.digicert.com/DigiCertGlobalG3TLSECCSHA3842020CA1-2.crt X509v3 Basic Constraints: critical CA:FALSE CT Precertificate SCTs: Signed Certificate Timestamp: Version : v1 (0x0) Log ID : 12:F1:4E:34:BD:53:72:4C:84:06:19:C3:8F:3F:7A:13: F8:E7:B5:62:87:88:9C:6D:30:05:84:EB:E5:86:26:3A Timestamp : Jun 25 23:46:14.235 2024 GMT Extensions: none Signature : ecdsa-with-SHA256 30:44:02:20:02:39:EC:06:AB:8F:66:5D:C3:5A:05:19: 85:52:BA:F1:29:7B:6C:37:7E:A5:31:D3:8B:33:82:22: 57:76:3C:8B:02:20:58:85:1C:35:E7:4D:86:4B:80:30: 05:A1:C2:4B:1E:DE:06:5C:38:AD:DC:21:7C:3C:85:52: 3A:13:47:5F:25:54 Signed Certificate Timestamp: Version : v1 (0x0) Log ID : E6:D2:31:63:40:77:8C:C1:10:41:06:D7:71:B9:CE:C1: D2:40:F6:96:84:86:FB:BA:87:32:1D:FD:1E:37:8E:50 Timestamp : Jun 25 23:46:14.182 2024 GMT Extensions: none Signature : ecdsa-with-SHA256 30:46:02:21:00:80:E0:43:48:49:B1:FB:86:C6:19:15: 22:72:2C:92:FD:78:E2:F2:D4:C6:49:AC:EE:37:AF:F0: FA:F1:0D:81:12:02:21:00:C3:1E:8B:AC:E1:44:C1:C9: 4E:85:C2:15:C9:FB:02:AF:2F:88:F5:F6:DF:73:D0:AE: 6F:6D:E1:45:F1:DC:AB:54 Signed Certificate Timestamp: Version : v1 (0x0) Log ID : DD:DC:CA:34:95:D7:E1:16:05:E7:95:32:FA:C7:9F:F8: 3D:1C:50:DF:DB:00:3A:14:12:76:0A:2C:AC:BB:C8:2A Timestamp : Jun 25 23:46:15.187 2024 GMT Extensions: none Signature : ecdsa-with-SHA256 30:45:02:20:24:7D:CF:AB:2A:FD:A6:82:F5:93:D6:88: F3:F9:A9:24:7D:9D:EC:3F:6E:17:48:0E:88:29:C3:2E: 8B:8F:21:F8:02:21:00:9C:BB:32:2E:4E:1E:A7:2A:FC: D9:41:88:32:89:70:5B:D5:27:CD:86:1C:7E:39:E9:E9: 50:F8:6B:29:06:EA:CD Signature Algorithm: ecdsa-with-SHA384 Signature Value: 30:64:02:30:1d:f5:bd:91:c6:2e:d8:1d:08:22:2b:e8:9d:6a: 22:98:0d:e0:7a:c2:66:6b:6a:cf:e4:12:3c:7e:d8:2e:e1:06: 23:38:af:3e:1b:ac:6e:d1:dc:b1:7f:cb:a0:23:cb:f4:02:30: 79:2d:95:1c:ad:ea:72:4e:22:d0:78:f4:6b:ef:79:60:cb:6b: ed:fd:94:9b:6d:ae:20:be:de:a4:18:ab:76:83:81:9a:5f:d6: f2:db:2d:58:8b:7e:dc:25:b0:8a:38:7b